Insider Selling: Diaceutics PLC (LON:DXRX) Insider Sells 500,000 Shares of Stock

Diaceutics PLC (LON:DXRX - Get Free Report) insider Peter Keeling sold 500,000 shares of Diaceutics stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of GBX 126 ($1.67), for a total transaction of £630,000 ($835,765.46).

Diaceutics Stock Down 1.5%

Diaceutics stock opened at GBX 130 ($1.72) on Thursday. The company has a current ratio of 4.85, a quick ratio of 9.92 and a debt-to-equity ratio of 0.39. Diaceutics PLC has a 1-year low of GBX 103 ($1.37) and a 1-year high of GBX 151 ($2.00). The company has a fifty day simple moving average of GBX 120.46 and a 200 day simple moving average of GBX 126.98. The company has a market cap of £109.71 million, a P/E ratio of -38.56 and a beta of 0.58.

Diaceutics (LON:DXRX - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported GBX (2.02) (($0.03)) earnings per share for the quarter. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%. Research analysts anticipate that Diaceutics PLC will post 1.0107919 earnings per share for the current fiscal year.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.